Item 4 of the Schedule 13D is hereby amended and supplemented as follows: On November 25, 2025, the Company disclosed that it ceased its dilutive issuances of securities under its at-the-market ("ATM") offering program on November 7, 2025, the last business day prior to our nomination of director candidates and submission of our prior offer to acquire the Company for $5.20 per share (the "Initial Offer"). On November 14, 2025, we withdrew our Initial Offer directly as a result of the Company's disclosure of a transformational issuance of shares, increasing the share count by 128% over a four-week period. As we have consistently stated since the withdrawal, we continue to stand behind the economics behind our Initial Offer - however, the massive and potentially continuing dilution at indeterminate prices had made it impossible to determine a specific offer price that would capture those economics. As a result of the Company's disclosure that it has ceased issuing shares, we are in the process of recalculating and resubmitting a revised offer based on the assumption that no further issuances will occur during the pendency of the strategic review and incorporating the economics of these value-destructive stock issuances.